Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV
Open Access
- 15 January 2025
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 24 (5) , e14468
Abstract
Due to the increased burden of non‐AIDS‐related comorbidities in people living with HIV (PLHIV), identifying biomarkers and mechanisms underlying premature aging and the risk of developing age‐related comorbidities is a priority. Evidence suggests that the plasma proteome is an accurate source for measuring biological age and predicting age‐related clinical outcomes. To investigate whether PLHIV on antiretroviral therapy (ART) exhibit a premature aging phenotype, we profiled the plasma proteome of two independent cohorts of virally suppressed PLHIV (200HIV and 2000HIV) and one cohort of people without HIV (200FG) using O‐link technology. Next, we built a biological age‐prediction model and correlated age advancement (the deviation of the predicted age from the chronological age) with HIV‐related factors, comorbidities, and cytokines secreted by immune cells. We identified a common signature of 77 proteins associated with chronological age across all cohorts, most of which were involved in inflammatory and senescence‐related processes. PLHIV showed increased age advancement compared to people without HIV. In addition, age advancement in the 2000HIV cohort was positively associated with prior hepatitis C and cytomegalovirus (CMV) infections, non‐AIDS‐related comorbidities, ART duration, cumulative exposure to the protease inhibitor Ritonavir, as well as higher production of monocyte‐derived proinflammatory cytokines and chemokines and lower secretion of T‐cell derived cytokines. Our proteome‐based predictive model is a promising approach for calculating the age advancement in PLHIV. This will potentially allow for further characterization of the pathophysiological mechanisms linked to accelerated aging and enable monitoring the effectiveness of novel therapies aimed at reducing age‐related diseases in PLHIV.Keywords
Funding Information
- ViiV Healthcare (A18‐1052)
This publication has 46 references indexed in Scilit:
- Biomarkers of aging for the identification and evaluation of longevity interventionsCell, 2023
- Epigenetic clock: A promising biomarker and practical tool in agingAgeing Research Reviews, 2022
- Accelerated aging with HIV occurs at the time of initial HIV infectioniScience, 2022
- Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1Journal of the International AIDS Society, 2021
- Extensive remodeling of the extracellular matrix during aging contributes to age-dependent impairments of muscle stem cell functionalityCell Reports, 2021
- Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trialThe Lancet HIV, 2021
- GDF15 as a biomarker of ageingExperimental Gerontology, 2021
- Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohortThe Lancet Public Health, 2017
- Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cellsEuropean Journal of Cell Biology, 2016
- The end of AIDS: HIV infection as a chronic diseaseThe Lancet, 2013